Researchers at The Ottawa Hospital and the University of Ottawa
New mouse model may speed identification of promising muscular dystrophy therapies
A Massachusetts General Hospital (MGH) research team has created a
Extracellular RNA in urine may provide useful biomarkers for muscular dystrophy
Massachusetts General Hospital (MGH) researchers have found that extracellular RNA
Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy
August 30, 2018 – Pfizer Inc. (NYSE: PFE) announced today